IL222080B - 6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives - Google Patents
6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivativesInfo
- Publication number
- IL222080B IL222080B IL222080A IL22208012A IL222080B IL 222080 B IL222080 B IL 222080B IL 222080 A IL222080 A IL 222080A IL 22208012 A IL22208012 A IL 22208012A IL 222080 B IL222080 B IL 222080B
- Authority
- IL
- Israel
- Prior art keywords
- thieno
- quinolin
- derivatives
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31860610P | 2010-03-29 | 2010-03-29 | |
| PCT/US2011/030278 WO2011123419A1 (en) | 2010-03-29 | 2011-03-29 | Trycyclic compounds and pbk inhibitors containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL222080B true IL222080B (en) | 2018-05-31 |
Family
ID=44712585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL222080A IL222080B (en) | 2010-03-29 | 2012-09-23 | 6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8962648B2 (enExample) |
| EP (1) | EP2552206B1 (enExample) |
| JP (1) | JP5849302B2 (enExample) |
| KR (1) | KR101757502B1 (enExample) |
| CN (1) | CN102917590B (enExample) |
| AU (1) | AU2011235319B2 (enExample) |
| BR (1) | BR112012023836B1 (enExample) |
| CA (1) | CA2792941C (enExample) |
| DK (1) | DK2552206T3 (enExample) |
| ES (1) | ES2547571T3 (enExample) |
| IL (1) | IL222080B (enExample) |
| MX (1) | MX2012011412A (enExample) |
| SG (1) | SG184376A1 (enExample) |
| TW (1) | TWI503323B (enExample) |
| WO (1) | WO2011123419A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201990240A1 (ru) * | 2013-12-24 | 2019-06-28 | Бристол-Маерс Сквибб Компани | Новые трициклические соединения в качестве противораковых средств |
| TWI557011B (zh) | 2015-05-25 | 2016-11-11 | 可影像處理的自行車錶裝置 | |
| EP3307725A1 (en) | 2015-06-11 | 2018-04-18 | Basilea Pharmaceutica International AG | Efflux-pump inhibitors and therapeutic uses thereof |
| GB201617758D0 (en) | 2016-10-20 | 2016-12-07 | Almac Discovery Limited | Pharmaceutical compounds |
| CN108341774B (zh) * | 2017-01-25 | 2022-07-19 | 首药控股(北京)股份有限公司 | 取代的喹啉酮类抑制剂 |
| BR112019021136A2 (pt) | 2017-04-10 | 2020-07-21 | Bayer Aktiengesellschaft | n-ariletil-2-arilquinolina-4-carboxamidas substituídas e uso das mesmas |
| US12024715B2 (en) | 2017-11-07 | 2024-07-02 | Temple University-Of The Commonwealth System Of Higher Education | Compositions and methods for improved T cells |
| CN111099941B (zh) * | 2018-10-26 | 2022-10-18 | 中国科学院上海有机化学研究所 | 一种烷基腈类化合物的制备方法 |
| TW202300150A (zh) * | 2021-03-18 | 2023-01-01 | 美商薛定諤公司 | 環狀化合物及其使用方法 |
| CN117362304A (zh) * | 2022-07-07 | 2024-01-09 | 深圳微芯生物科技股份有限公司 | 一种甲酰胺取代的杂三环类衍生物、其制备方法及其应用 |
| WO2024097228A1 (en) * | 2022-10-31 | 2024-05-10 | Meliora Therapeutics, Inc. | Compounds targeting cdk11 and methods of using the same |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5377096A (en) * | 1976-12-17 | 1978-07-08 | Teijin Ltd | Preparation of thieno 2,3-c quinolin-4(5h)-one-7-acetic acids |
| FR2636063B1 (fr) * | 1988-09-05 | 1993-04-30 | Centre Nat Rech Scient | Composes phenylpyrroliques utiles en tant que medicaments, leur preparation et leur application |
| DE19806348A1 (de) * | 1998-02-12 | 1999-08-19 | Schering Ag | 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln |
| US6506769B2 (en) | 1999-10-06 | 2003-01-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| US6638929B2 (en) * | 1999-12-29 | 2003-10-28 | Wyeth | Tricyclic protein kinase inhibitors |
| ATE353320T1 (de) * | 1999-12-29 | 2007-02-15 | Wyeth Corp | Tricyclische proteinkinasehemmer |
| DE10242106A1 (de) | 2002-09-11 | 2004-04-15 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Phosphorgruppenhaltige Carbonsäurederivate mit organisch polymerisierbaren Gruppen |
| KR20050057404A (ko) | 2002-09-17 | 2005-06-16 | 워너-램버트 캄파니 엘엘씨 | 정신분열증 치료용 헤테로환 치환된 피페라진 |
| WO2004035577A2 (en) * | 2002-10-16 | 2004-04-29 | Gilead Sciences, Inc. | Pre-organized tricyclic integrase inhibitor compounds |
| GB0501999D0 (en) * | 2005-02-01 | 2005-03-09 | Sentinel Oncology Ltd | Pharmaceutical compounds |
| PT2061765E (pt) * | 2006-09-01 | 2015-02-06 | Senhwa Biosciences Inc | Moduladores de serina-treonina-proteína-quinase e de parp |
| WO2009010804A1 (en) * | 2007-07-19 | 2009-01-22 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Macrocyclic compounds as antiviral agents |
| AU2009219154A1 (en) * | 2008-02-29 | 2009-09-03 | Cylene Pharmaceuticals, Inc. | Protein kinase modulators |
-
2011
- 2011-03-28 TW TW100110555A patent/TWI503323B/zh not_active IP Right Cessation
- 2011-03-29 CN CN201180026805.8A patent/CN102917590B/zh active Active
- 2011-03-29 JP JP2013502740A patent/JP5849302B2/ja active Active
- 2011-03-29 ES ES11763307.3T patent/ES2547571T3/es active Active
- 2011-03-29 MX MX2012011412A patent/MX2012011412A/es active IP Right Grant
- 2011-03-29 EP EP11763307.3A patent/EP2552206B1/en active Active
- 2011-03-29 DK DK11763307.3T patent/DK2552206T3/en active
- 2011-03-29 US US13/202,544 patent/US8962648B2/en active Active
- 2011-03-29 CA CA2792941A patent/CA2792941C/en active Active
- 2011-03-29 KR KR1020127027125A patent/KR101757502B1/ko not_active Expired - Fee Related
- 2011-03-29 WO PCT/US2011/030278 patent/WO2011123419A1/en not_active Ceased
- 2011-03-29 BR BR112012023836-1A patent/BR112012023836B1/pt not_active IP Right Cessation
- 2011-03-29 AU AU2011235319A patent/AU2011235319B2/en not_active Ceased
- 2011-03-29 SG SG2012072807A patent/SG184376A1/en unknown
-
2012
- 2012-09-23 IL IL222080A patent/IL222080B/en active IP Right Grant
-
2014
- 2014-12-09 US US14/565,047 patent/US9453025B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2792941A1 (en) | 2011-10-06 |
| MX2012011412A (es) | 2013-02-07 |
| TWI503323B (zh) | 2015-10-11 |
| JP5849302B2 (ja) | 2016-01-27 |
| BR112012023836B1 (pt) | 2022-02-01 |
| AU2011235319A1 (en) | 2012-10-11 |
| JP2013523749A (ja) | 2013-06-17 |
| TW201136939A (en) | 2011-11-01 |
| US20130178459A1 (en) | 2013-07-11 |
| RU2012145855A (ru) | 2014-05-10 |
| EP2552206A4 (en) | 2013-08-14 |
| HK1179114A1 (en) | 2013-09-27 |
| SG184376A1 (en) | 2012-11-29 |
| CA2792941C (en) | 2017-09-12 |
| WO2011123419A1 (en) | 2011-10-06 |
| US8962648B2 (en) | 2015-02-24 |
| US20150183799A1 (en) | 2015-07-02 |
| DK2552206T3 (en) | 2015-09-28 |
| KR101757502B1 (ko) | 2017-07-12 |
| ES2547571T3 (es) | 2015-10-07 |
| BR112012023836A2 (pt) | 2015-09-22 |
| CN102917590B (zh) | 2016-02-17 |
| EP2552206A1 (en) | 2013-02-06 |
| US9453025B2 (en) | 2016-09-27 |
| EP2552206B1 (en) | 2015-07-22 |
| CN102917590A (zh) | 2013-02-06 |
| KR20130020666A (ko) | 2013-02-27 |
| AU2011235319B2 (en) | 2016-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL222080B (en) | 6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives | |
| AP2939A (en) | Thieno [2,3-B] pyridine derivatives as viral replication inhibitors | |
| IL213993A (en) | History of 4,3,2,1-tetrahydropyrido [3,2-b] pyrazine-2-one and pharmaceutical preparations containing them | |
| IL216452A0 (en) | 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES | |
| ZA201206630B (en) | Hetaryl-[1,8]naphthyridine derivatives | |
| ZA201205788B (en) | 1,2,4-triazine-4-amine derivatives | |
| PL2740476T3 (pl) | Pochodne cis-tetrahydro-spiro(cykloheksano-1,1'-pirydo[3,4-b]indolo)-4-aminy | |
| IL220432A (en) | History of theo [b – 3,2] pyridinedione and pharmaceutical preparations containing them | |
| IL224903A (en) | Imidzo [c – 5,4] quinolines as DNA inhibitors | |
| ZA201108885B (en) | 3-([1,2,3]triazole-4yl)-pyrrolo[2,3-b]pyridine derivates | |
| IL218490A0 (en) | Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof | |
| PL2513119T3 (pl) | Pochodne 3,4,4a,10b-tetrahydro-1H-tiopirano-[4,3-c]izochinoliny | |
| IL232717A0 (en) | 3-cyanoaryl-h1-pyrrolo[b-3,2]pyridine derivatives | |
| IL229993A (en) | 8 - Alkoxy [1,2,4] triazolo [5,1 – c] pyrimidine– 2 | |
| IL222356A0 (en) | Substituted 2,3-dihydroimidazo [1,2-c]quinazoline-containing combinations | |
| ZA201301313B (en) | Herbicidal isoxazolo[5,4-b]pyridines | |
| IL221479A0 (en) | Triazolo [4,5-b] pyridin derivatives | |
| PT2646011T (pt) | Métodos para a redução da compulsão alimentar periódica ou alimentação compulsiva | |
| ZA201302112B (en) | 1,4-oxazepane derivatives | |
| GB2476643B (en) | 1,4-Dihydro-1,4-dioxonaphtalene derivatives as anticoagulants | |
| AP2012006419A0 (en) | Aminoquinoline derivatives | |
| PL390846A1 (pl) | Pochodne 5,11-dimetylo-5H-indolo[2,3-b]chinoliny | |
| PL2850070T3 (pl) | Pochodne benzo[1,3]dioksyny i ich zastosowanie jako antagonistów LPAR5 | |
| IL219623A0 (en) | [1,5]-diazocin derivatives | |
| PL391537A1 (pl) | Barwne sulfoniany 9-(2-karboksyfenylo)-3,6-dihydroksy-9H-ksanten-9-yliowe oraz sposób ich otrzymywania |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |